Company: GMRE
Filing Date: 2025-03-31
Form Type: DEF 14A
Source: 0001104659-25-029872
Chunk: 76

Company: Global Medical REIT Inc.
Filing Date: 2025-03-31
Form: DEF 14A
Chunk 76
---
 awards (which reflects the plan performance goals that had been achieved as of December 31, 
 2024) and assumes the executive achieved the target level of the discretionary component           
 of the award, (iii) 0% of the executive’s target 2022 Long-Term Equity Incentive                   
 Plan awards, which represents the amount due based on an assumed acquisition stock price           
 of $7.72 on December 31, 2024 after the application of a partial service factor, (iv) 0%           
 of the executive’s aggregate target 2023 Long-Term Equity Incentive Plan awards, which             
 represents the amount due based on an assumed acquisition stock price of $7.72 on December 31,     
 2024 after the application of a partial service factor and (v) 0% of the executive’s               
 aggregate target 2024 Long-Term Equity Incentive Plan awards, which represents the amount          
 due based on an assumed acquisition stock price of $7.72 on December 31, 2024 after                
 the application of a partial service factor.                                                       |

| (8) | Represents COBRA payments for (i) a maximum of 18 months with respect            
 to Messrs. Busch, Kiernan and Leon and (ii) a maximum of 12 months with respect  
 to Mr. Barber and Mrs. Holley. Amounts are based on the monthly health insurance 
 premium paid by the Company for the month of December 2024.                      |

SECURITIES AUTHORIZED FOR ISSUANCE UNDER EQUITY COMPENSATION PLANS The following table sets forth information as of December 31, 2024, with respect to compensation plans under which our equity securities are authorized for issuance, specifically, the 2016 Plan. We have no such plans that were not approved by security holders.

| Plan Category                                              |     | Number                  
 of securities to        
 be issued upon exercise 
 of outstanding options, 
 warrants and rights (a) |           |    |     | Weighted-average        
 exercise price of our   
 outstanding options,    
 warrants and rights (b) |     | Number                  
 of securities           
 remaining available for 
 issuance under equity   
 compensation plans      
 (excluding              
 securities reflected    
 in column (a) (c)       |           |
| Equity compensation plans approved by security holders     |     |                         | 3,095,552 | -1 |     | N/A                     |     |                         | 2,136,845